✦ LIBER ✦

Raltitrexed plus cisplatin is cost-effective compared with pemetrexed plus cisplatin in patients with malignant pleural mesothelioma

✍ Scribed by Woods, Beth; Paracha, Noman; Scott, David A.; Thatcher, Nicholas

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-Effectiveness of Pemetrexed Plus Ci

✍ Anna Cordony; Corinne Le Reun; Antje Smala; James T. Symanowski; Jessamy Watkins 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

P-435 Long-term survival update from the

✍ Vogelzang, N.; Symanowski, J.; Rusthoven, J.; Manegold, C.; Boyer, M.; Nguyen, B 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 323 KB

Single-arm, open label study of pemetrex

✍ Obasaju, Coleman K.; Ye, Zhishen; Wozniak, Antoinette J.; Belani, Chandra P.; Ke 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 330 KB

P-513 Improving pulmonary function in pa

✍ Pistolesi, M.; Symanowski, J.; Gatzemeier, U.; Emri, S.; Conte, P.; Manegold, C. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 193 KB

Pemetrexed plus carboplatin in elderly p

✍ Bearz, A; Castagneto, B; Zucali, P A; Favaretto, A; Mencoboni, M; Grossi, F; Cor 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 135 KB

905 Documenting symptom palliation with

✍ R. Gralla; P. Hollen; A. Liepa; J. Symanowski; J. Rusthoven; M. Boyer; J. Jassem 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 164 KB